22 and older, any sex, with Gastrointestinal Disease or Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
The Rate of Adequate Cleansing Level Before and After the Use of the Pure-Vu SystemPrimary· up to 2 hours
The rate of adequate cleansing level in each colon segment before and after use of Pure-Vu will be evaluated using the Boston Bowel Preparation Scale (BBPS). Segment score of 0-3 given to each of the 3 segments of the colon (Left side, Transverse and right side) summed for the maximum score of 9 (0= dirtiest and 9= pristine).
An adequate cleansing procedure will be considered when all the colon segments will be graded as 2 or above.
Rate of adequate preparation measured by BBPS before Pure-Vu Use
Group
Value
95% CI
Colonoscopy With Pure-Vu System
38
28 – 49
Rate of adequate preparation measured by BBPS after Pure-Vu Use
Group
Value
95% CI
Colonoscopy With Pure-Vu System
96
90 – 99
Adverse events — posted to ClinicalTrials.gov
Time frame: From procedure to 48 hours post procedure.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
The aim of this study is to evaluate the potential improvement in colonoscopy procedure's outcomes when using the Pure-Vu System in hospitalized patients who are indicated for colonoscopy procedure.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT04700410 — Bowel Cleansing Performance of the Pure-Vu System in Patients With a History of Poor Bowel Preparation
· NA
· completed
NCT04285008 — Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who
· NA
· withdrawn
NCT03922906 — Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation
· NA
· terminated
NCT03493009 — Optimizing the Preparation Regime Prior to Colonoscopy Procedure With Pure-Vu System
· NA
· withdrawn
Other recruiting trials for Gastrointestinal Disease
Currently open trials in the same condition.
NCT05053191 — Advancing Nursing Practices in Hospital Oncology Care
· NA
· active not recruiting
NCT04949282 — Spanish Series of Patients Treated With the Radionuclide Lutetium177
· recruiting
NCT03566160 — Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy
· NA
· active not recruiting
Other Motus GI Medical Technologies Ltd trials
Trials by the same sponsor.
NCT05585879 — Demonstrating Effective Salvage of Inadequate Colonoscopies
· NA
· terminated
NCT04285008 — Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who
· NA
· withdrawn
NCT03922906 — Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation
· NA
· terminated
NCT03493009 — Optimizing the Preparation Regime Prior to Colonoscopy Procedure With Pure-Vu System
· NA
· withdrawn
NCT03026075 — Evaluation of the Performance of the Motus Cleansing System (MCS)
· NA
· completed
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Motus GI Medical Technologies Ltd
Last refreshed: 13 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03503162.